Seropositivity and trends of transfusion transmitted infections among blood donors at blood center of tertiary care hospital of Marathwada region, Maharashtra, India
DOI:
https://doi.org/10.18203/2320-6012.ijrms20264180Keywords:
Malaria, Syphilis, Hepatitis C virus, Hepatitis B virus, Human immunodeficiency virus, Transfusion transmitted infections, SeropositivityAbstract
Background: Blood transfusion is a life-saving intervention that has an essential role in patient management within health care system. The establishment of systems to ensure that all donated blood screened for transfusion -transmissible infections is a core component of every national blood programme. Testing for TTI’s before blood transfusion is crucial for safety of recipients. with each unit of blood, there is 1% chance of transfusion associated problems including TTI.
The aim of this 5-year retrospective study was to analyze the trend of transfusion transmitted infections among blood donors to evaluate the seroprevalence of HIV, HBV, HCV, syphilis and malaria.
Methods: A retrospective study was done at the blood center over a period of 5 years from January 2020 to December 2024 in healthy donors aged between 18-65 years. TTIs were performed using ELISA for HIV, HBV, HCV and HBsAg, peripheral blood smear for malaria and RPR (Rapid Plasma Reagin) for syphilis.
Results: Out of total 64603 healthy voluntary donors, prevalence of HIV, HBV, HCV, syphilis and malaria was (14) 0.021%, (257) 0.397%, (38) 0.058%, (12) 0.018% and 0 % respectively in our study.
Conclusions: Implementation of strict donor selection criteria along with proper counselling of donors can help to decrease seroprevalence rate of transfusion transmitted diseases. Also, the prevalence rate can be useful for government and health administrative services to implement better policy for safe blood collection and transfusion.
References
Patel SK, Mehta RP, Chilani AH, Mistry KJ, Pandya DP, Nayak RC. Seropositivity and trends of transfusion transmitted infections among blood donors: five years cross-sectional study on 20,392 blood donors in a tertiary care hospital of Ahmedabad, Gujarat, India. J Clin Diagn Res. 2024;18(2):EC06-11.
Buseri FI, Muhibi MA, Jeremiah ZA. Sero-epidemiology of transfusion-transmissible infectious diseases among blood donors in Osogbo, south-west Nigeria. Blood Transfus. 2009;7(4):293-9.
Srikrishna A, Sitalakshmi S, Damodar P. How safe are our safe donors? Indian J Pathol Microbiol. 1999;42(4):411-6.
Arora I, Singh S, Singh S. Seroprevalence and trends of transfusion transmitted infections in blood donors of rural tertiary care hospital blood bank: a 3-year retrospective study in Chamba (HP). Int J Community Med Public Health. 2018;5(6):2453-7.
Tessema B, Yismaw G, Kassu A, Amsalu A, Mulu A, Emmrich F, et al. Seroprevalence of HIV, HBV, HCV and syphilis infections among blood donors at Gondar University Teaching Hospital, Northwest Ethiopia: declining trends over a period of five years. BMC Infect Dis. 2010;10:111.
Sharma R, Cheema R, Vajpayee M, Rao U, Kumar S, Marwaha N. Prevalence of markers of transfusion transmissible diseases in voluntary and replacement blood donors. Natl Med J India. 2004;17(1):19-21.
Kakkar N, Kaur R, Dhanoa J. Voluntary donors: need for a second look. Indian J Pathol Microbiol. 2004;47:381-3.
Singh B, Kataria SP, Gupta R. Infectious markers in blood donors of East Delhi: prevalence and trends. Indian J Pathol Microbiol. 2004;47:477-9.
Nanu A, Sharma SP, Chatterjee K, Jyoti P. Markers for transfusion-transmissible infections in north Indian voluntary and replacement blood donors: prevalence and trends 1989-1996. Vox Sang. 1997;73(2):70-3.
Garg S, Mathur D, Garg D. Comparison of seropositivity of HIV, HBV, HCV and syphilis in replacement and voluntary blood donors in western India. Indian J Pathol Microbiol. 2001;44:409-12.
Choudhury N, Ramesh V, Saraswat S, Naik S. Effectiveness of mandatory transmissible diseases screening in Indian blood donors. Indian J Med Res. 1995;101:229-32.
Chandrasekaran S, Palaniappan N, Krishnan V, Mohan G, Chandrasekaran N. Relative prevalence of hepatitis B viral markers and hepatitis C virus antibodies (anti-HCV) in Madurai, south India. Indian J Med Sci. 2000;54:270-3.
Srikrishna A, Sitalakshmi S, Damodar P. How safe are our safe donors? Indian J Pathol Microbiol. 1999;42(4):411-6.
Gupta N, Kumar V, Kaur A. Seroprevalence of HIV, HBV, HCV and syphilis in voluntary blood donors. Indian J Med Sci. 2004;58:255-7.
van der Sluis JJ, ten Kate FJ, Vuzevski VD, Kothe FC, Aelbers GM, van Eijk RV. Transfusion syphilis, survival of Treponema pallidum in stored donor blood. II. Dose dependence of experimentally determined survival times. Vox Sang. 1985;49(6):390-9.
Ahmadpour E, Foroutan-Rad M, Majidiani H, Mehrani Moghaddam S, Hatam-Nahavandi K, Hosseini SA, et al. Transfusion-transmitted malaria: a systematic review and meta-analysis. Open Forum Infect Dis. 2019;6(7):ofz283.
World Health Organization. The clinical use of blood in medicine, obstetrics, paediatrics, surgery and anaesthesia, trauma and burns. Geneva: World Health Organization; 2001. Available from: https://iris.who.int/bitstream/handle/10665/42397/a72894.pdf?sequence=1 Accessed on 20 August 2026.
Menitove JE. How safe is blood transfusion? In Smith DM, Dodd RY, eds.Transfusion Transmitted Infections. ASCP press, Chicago 1991; 1–22.
United States General Accounting Office. Blood supply: FDA oversight and remaining issues of safety. Washington (DC): United States General Accounting Office; 1997. Report No.: GAO/PEMD-97-1. Available from: https://www.gao.gov/assets/pemd-97-1.pdf Accessed on 202 August 2026.
Arora D, Arora B, Khetarpal A. Seroprevalence of HIV, HBV, HCV and syphilis in blood donors in Southern Haryana. Indian J Pathol Microbiol. 2010;53(2):308-9.
Mittal N, Rajput S, Kumar S, Das B. Transfusion transmissible infections (TTIs): trends and seroprevalence among blood donors at blood center of a tertiary care hospital: a 5-year study. Paripex Indian J Res. 2019;8
Mohammed Y, Bekele A. Seroprevalence of transfusion transmitted infection among blood donors at Jijiga blood bank, Eastern Ethiopia: retrospective 4 years study. BMC Res Notes. 2016;9:129.
Anjali H, Issac A, Anjali MR, Anish TS. Transfusion-transmissible infections among voluntary blood donors at Government Medical College Thiruvananthapuram, Kerala, India. Asian J Transfus Sci. 2012 Jan;6(1):55-6.
Pallavi P, Ganesh CK, Jayashree K, Manjunath GV. Seroprevalence and trends in transfusion transmitted infections among blood donors in a university hospital blood bank: a 5 year study. Indian J Hematol Blood Transfus. 2011;27:1-6.
Pahuja S, Sharma M, Baitha B, Jain M. Prevalence and trends of markers of hepatitis C virus, hepatitis B virus and human immunodeficiency virus in Delhi blood donors: a hospital based study. Jpn J Infect Dis. 2007;60:389-91.
Matee MI, Magesa PM, Lyamuya EF. Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among blood donors at the Muhimbili National Hospital in Dar es Salaam, Tanzania. BMC Public Health. 2006;6:21.
Cheema S, Rana V, Kulhari K, Yadav A, Sachdeva A. Prevalence of transfusion transmissible infections and associated factors among healthy blood donors in North Indian population: 4-year experience of licensed blood bank at tertiary care hospital. J Mar Med Soc. 2022;24:47-52.
Gupta R, Singh B, Singh DK, Chugh M. Prevalence and trends of transfusion transmitted infections in a regional blood transfusion centre. Asian J Transfus Sci. 2011;5:177-8.
Mendhe VV, Dongre DT. Prevalence and trends of transfusion transmitted infections among voluntary blood donors in a blood bank of tertiary care hospital in Nagpur, 2017-2021. Int J Med Sci Clin Res Stud. 2023;3(1):63-7.
Prakash VB, Navyashree N, Deepthi KS. Prevalence of seropositive cases among blood donors: a 10 years retrospective study in a tertiary care hospital. Saudi J Pathol Microbiol. 2020;5(1):39-42.
Kaur G, Basu S, Kaur R, Kaur P, Garg S. Patterns of infections among blood donors in a tertiary care centre: a retrospective study. Natl Med J India. 2010;23(3):147-9.
Makroo RN, Hegde V, Chowdhry M, Bhatia A, Rosamma NL. Seroprevalence of infectious markers and their trends in blood donors in a hospital-based blood bank in north India. Indian J Med Res. 2015;142(3):317-22.
Sethi B, Kumar S, Butola KS, Mishra JP, Kumar Y. Seroprevalence pattern among blood donors in a tertiary health care center. Internet J Med Update. 2014;9(1):10-5.
Bhawani Y, Rao PR, Sudhakar V. Seroprevalence of transfusion transmissible infections among blood donors in a tertiary care hospital of Andhra Pradesh from 2004-2009. Biol Med. 2010;2(4):45-8.
Leena M, Mohd S. Trend and prevalence of transfusion transmitted infections among blood donors in rural teaching institute, south India. J Pathol Nepal. 2012;2(3):203-6.
Mandal R, Mondal K. Transfusion transmissible infections among blood donors from a sub-Himalayan rural tertiary care centre in Darjeeling, India. J Tradit Complement Med. 2016;6(3):224-9.
National AIDS Control Organisation, National Blood Transfusion Council. Assessment of NACO supported blood banks: a preliminary report 2016. New Delhi: National AIDS Control Organisation; 2016. Available from: https://asbtc.assam.gov.in/sites/default/files/swf_utility_folder/departments/asbtc_lipl_in_oid_11/menu/document/Assessment%20of%20NACO%20supported%20BBs%20in%20India.pdf. Accessed on 20 August 2026.
Naik VSS, Neeraja M, Sujeeva Swapna R, Bhavani C, Sravani P, Suman Kumar TCS. Seroprevalence of transfusion transmitted infections in voluntary and replacement blood donors in a tertiary care hospital blood bank of Anantapur, Andhra Pradesh, India: 5 years retrospective study. Int J Res Med Sci. 2020;8(2):455-9.
Arif SH, Alam K, Saeed N, Shams A, Hassan MJ. Association of ABO and RH blood group with transfusion transmitted infections (TTI) among blood donors in north India. Indian J Pathol Oncol. 2021;8(2):271-5.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Ashwini R. Tangde, Vijaya Wane, B. R. Sonwane

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.